After falling 17 per cent since the start of the year to its March lows, the stock of the country’s largest pharmaceutical ...

Sun Pharmaceutical Industries Ltd. closed 14.89% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

After a legal decision delayed its entry last fall, Sun Pharma has received the all-clear to tap into the U.S. | After Sun ...

Glenmark, Sun Pharma, and Zydus are recalling various products in the US due to manufacturing issues and CGMP deviations, ...

The rise in the Sun Pharma share price came after a favourable ruling from a US court regarding its planned launch of ...

Emkay Global maintains a 'Buy' rating on Sun Pharma after the US Court of Appeals vacates the injunction against Leqselvi's ...

Sun Pharmaceutical Industries Ltd. closed 13.91% short of its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

Art Garfunkel is breaking the sound of silence around his experience with plaque psoriasis. | Art Garfunkel is breaking the ...

Dilip Shanghvi had said in February that the judgment was crucial for Sun Pharma's future course of action on this drug ...

March 10, 2025 India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million India's Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics , a U.S.-based ...

Indian pharma players have been witnessing reprieve from price erosion and US product launches in the past few quarters. A ...

According to the USFDA, a Class II recall is issued when the use of or exposure to a violative product may cause temporary or ...